Home
Search
BIO Investor Forum    |   October 15-16, 2024

Speakers & Presenters

All Speakers
All Speakers
Filter by letter
A
B
C
D
E
F
G
H
I
J
K
L
M
N
O
P
Q
R
S
T
U
V
W
X
Y
Z
photo
Sabrina Martucci Johnson
PRESIDENT & CEO, DARé BIOSCIENCE
Daré Bioscience
San Diego, California, United States
photo
Maria Maccecchini, PHD
PRESIDENT & CEO, ANNOVIS BIO, INC.
Annovis Bio, Inc.
Berwyn, Pennsylvania, United States
photo
David Mann
CEO, VASCULAR BIOSCIENCES, INC.
Vascular BioSciences
Goleta, California, United States
photo
Dave Mantus
PRESIDENT US OPERATIONS, PULMOCIDE
Pulmocide
Boston , Massachusetts, United States
photo
Stephanie Marrus, MBA
MANAGING DIRECTOR, ENTREPRENEURSHIP, UNIVERSITY OF CALIFORNIA, SAN FRANCISCO
New Resources to Accelerate Translational Research
San Francisco, California, United States
photo
Trevor Martin
CO-FOUNDER AND CEO, MAMMOTH BIOSCIENCES
New Directions in Diagnostics Innovation
South San Francisco, California, United States
photo
Tyler Martin, MD
CEO, ADJUVANCE TECHNOLOGIES, INC.
Adjuvance Technologies, Inc.
Lincoln, Nebraska, United States
photo
Shinichi Matsumoto, PHD, MD
CHIEF SCIENTIFIC ADVISOR, OTSUKA PHARMACEUTICAL FACTORY, INC.
Otsuka Pharmaceutical Factory, Inc.
Kobe, Japan
photo
Glenn Mattes
PRESIDENT, CHIEF EXECUTIVE OFFICER AND DIRECTOR, TFF PHARMA
TFF Pharmaceuticals, Inc.
Austin, Texas, United States
photo
Mike Mattoon
VICE PRESIDENT, FEDERAL GOVERNMENT RELATIONS, BIOTECHNOLOGY INNOVATION ORGANIZATION
U.S. Election Outlook: Presidential & Congressional Scenario Planning for Biopharma Priorities
Washington, District of Columbia, United States
photo
David Mazzo, PHD
PRESIDENT & CEO, CALADRIUS BIOSCIENCES, INC
Caladrius Biosciences, Inc.
Basking Ridge, New Jersey, United States
photo
Joe McCann
CEO, POINT BIOPHARMA
POINT Biopharma
Toronto, Ontario, Canada
photo
Michelle McMurry-Heath
PRESIDENT AND CEO, BIOTECHNOLOGY INNOVATION ORGANIZATION
Biotech's Finest Hour: Progress Update on BIO Policy Work and COVID-19
Addressing Racism and Disparities during Therapeutic Development and in the Clinic
Washington, District of Columbia, United States
photo
Sara Michelmore
SENIOR VICE PRESIDENT, MACDOUGALL BIOMEDICAL COMMUNICATIONS
Market Outlook: Solid Ground or Thin Ice?
Natick, Massachusetts, United States
photo
Steve Miller, MD
EVP AND CHIEF CLINICAL OFFICER, CIGNA CORPORATION
New Directions in Diagnostics Innovation
Clayton, Missouri, United States
photo
Frank Minella
CEO, PAINQX
PainQx
New York, New York, United States
photo
James Moe, PHD, MBA
PRESIDENT, OLIGOMERIX, INC.
Oligomerix, Inc.
Bronx, New York, United States
photo
Katherine Moortgat
DIRECTOR, ABBVIE INC.
How to Pivot Neurodegeneration Treatment Research?
North Chicago, Illinois, United States
photo
Adi Mor, PHD
CO-FOUNDER AND CEO, CHEMOAMB
Chemomab
Tel Aviv, Israel
photo
Ana Moreno, PHD
CEO, NAVEGA THERAPEUTICS
Navega Therapeutics
San Diego, California, United States
photo
Jodie Morrison
CHIEF EXECUTIVE OFFICER, CADENT THERAPEUTICS
View from the Board: Managing Teams During a Pandemic
Cambridge, Massachusetts, United States
photo
Christopher Myatt, PHD
CEO, MBIO DIAGNOSTICS, INC
MBio Diagnostics | LightDeck
Boulder, Colorado, United States
Load More